ROM and Uganda Harm Reduction Network hosted delegates from VIIV Healthcare from the United Kingdom at Kisenyi Health Centre IV. The team was on a one-week learning visit in the country to gain a deeper understanding of the HIV Combination Prevention Service Delivery Model implemented by the partners among Adolescent Girls and Young Women (AGYW), People Who Inject Drugs (PWID) and other high risk population categories in the area in Kampala Region.
Interactions at Kisenyi Heath Center
From observing the implementation of the model, to insightful discussions with service providers on their role in ensuring provision of quality services, to one-on-one interactions with project beneficiaries, the delegates appreciated the impact of the project in in serving humanity.
In this service delivery model, ROM mobilizes clients from targeted hotspots and dens of People Who Inject Drugs. These receive a range of services that include HIV testing and counselling, risk reduction services aw well as linkage to both Pre Exposure Prophylaxis and Highly Active Antiretroviral Therapy care.
With continued support from Partners, ROM is committed to curbing the further spread of HIV among the less privileged members of the community it serves and enable those already living with HIV/AIDS to live responsible and dignified lives.
Ugandan Harm Reduction Network with support from VIIV health care is implementing the advocacy project for HIV combination prevention options. The project focuses on Amplifying the voices of Adolescent Girls and Young Women in their diversity to advocate for HIV combination prevention in Uganda.
This project aims to contribute to the reduction of HIV incidence among adolescent girls and young women (AGYW) in their diversity within Kampala City. Recognising the unique intersecting vulnerabilities and needs of this population, the project focuses on creating public awareness, improving access and acceptability of HIV combination prevention options, and developing targeted educational materials to enhance community engagement in the HIV response.
